DRAIC and prostate carcinoma: Another previous study showed that silencing of lncRNA PCAT29 increases proliferation and migration of prostate cancer cells, and overexpression lncRNA PCAT29 can suppress the growth and metastasis of prostate tumors, indicating that lncRNA PCAT29 is a tumor suppressor in prostate cancer [23].